If you’re on any medications for blood pressure, or know someone who is, then the following information may frighten you.
Not only is there quite a bit of data showing blood pressure meds don’t optimally correct or protect against the formation of deadly heart conditions…
There are now studies showing that some of these medications could result in cancer development.
Quite recently it was shown that a pharmaceutical company named Teva pharmaceuticals was manufacturing drugs that could lead to cancer.
They’re now in the process of recalling these drugs.
This is not the first, nor will it be the last, drug to produce this kind of dangerous result.
Now that FDA is assisting in the recall, they’re beginning a nationwide initiative to not just have them recalled… but they’re letting people know that this recall actually affects a wide variey of other drugs.
“In a statement from Teva posted by the Food and Drug Administration, the recall affects all lots of combination tablets featuring the drugs amlodipine and valsartan and another combo drug featuring amlodipine, valsartan, and hydrochlorothiazide.
The drugs could contain an impurity called N-nitroso-diethylamine (NDEA), which has been classified as a possible human carcinogen, the FDA said.
Patients taking either drugs should contact their doctor or pharmacist for advice or alternative treatments. Stopping the drugs immediately with no comparable alternative could pose a greater risk to patients’ health, said Teva.”
Customers and patients with questions can contact Teva by phone at 888-838-2872, or email at [email protected].
What’s scary isn’t just that these medications already pose dangers to us, as their long list of side effects is more than enough to cause damage to the human body…
It’s also scary that these drugs were even made with this impurity in the first place.
The FDA says they’re aware these kinds of problems with drug manufacturing crop up with some frequency and they’re renewing a commitment to make sure drugs aren’t made with these kinds of impurities in the first place.
Not long after this revelation was made, Scott Gottlieb, the commissioner of the FDA, admitted this egregious problem shows why attention to detail in the manufacturing process needs to be increased so this doesn’t happen again.
